Showing results (181-190 of 336) with videos related to
Sort By:
Pageof 34
European Journal of Medicinal Chemistry|February 1, 2023
Triazole-fused pyrimidines in target-based anticancer drug discoveryXing-Jie Dai, Lei-Peng Xue, Shi-Kun Ji, et al.International Immunopharmacology|June 8, 2024
Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriersMaa Mamun, Yi-Chao Zheng, Ning Wang, et al.Journal of Medicinal Chemistry|November 1, 2021
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug ResistanceShuai Wang, Sai-Qi Wang, Qiu-Xu Teng, et al.The Journal of Organic Chemistry|October 31, 2024
Functional Hexafluoroisopropyl Group Used in the Construction of Biologically Important Pyrimidine DerivativesShuo Yuan, Xiang Li, Yue-Lin Zhang, et al.European Journal of Pharmacology|January 20, 2019
A novel ent-kaurane diterpenoid analog, DN3, selectively kills human gastric cancer cells via acting directly on mitochondriaYong-Cheng Ma, Ying-Li Zhu, Nan Su, et al.Journal of Mass Spectrometry : JMS|January 15, 2009
Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometryHua-Yu Li, Shao-Min Wang, Hong-Min Liu, et al.Toxicology and Applied Pharmacology|September 6, 2016
A new brominated chalcone derivative suppresses the growth of gastric cancer cells in vitro and in vivo involving ROS mediated up-regulation of DR5 and 4 expression and apoptosisSaiyang Zhang, Tingyu Li, Yanbing Zhang, et al.Journal of Medicinal Chemistry|May 19, 2023
Discovery of Novel 1,3-Diphenylpyrazine Derivatives as Potent S-Phase Kinase-Associated Protein 2 (Skp2) Inhibitors for the Treatment of CancerKun Zhang, Kaizhao Hu, Qian Li, et al.European Journal of Medicinal Chemistry|March 9, 2023
Oxazolidinone: A promising scaffold for the development of antibacterial drugsShuo Yuan, Dan-Dan Shen, Yi-Ru Bai, et al.European Journal of Medicinal Chemistry|August 31, 2023
Micafungin: A promising inhibitor of UBE2M in cancer cell growth suppressionM A A Mamun, Shuan Liu, Lijie Zhao, et al.Pageof 34